PMID: 1088939Jan 1, 1975Paper

Serum migration inhibitory activity in patients with posttransplantation hepatic dysfunction

Clinical Immunology and Immunopathology
M TorisuS Cohen


No abstract listed.


Mar 7, 1964·JAMA : the Journal of the American Medical Association·T E STARZLW R WADDELL


Nov 1, 1979·Clinical Immunology and Immunopathology·A FassasC Jasmin
Apr 1, 1985·Australian and New Zealand Journal of Medicine·D S Nelson, C L Geczy
Jan 1, 1979·Annals of the New York Academy of Sciences·S Cohen, T Yoshida

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Related Papers

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Antony M Wheatley
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Jose M Morales
Le Journal médical libanais. The Lebanese medical journal
G J Frem, M H Sayegh
The New England Journal of Medicine
P M Lutterbeck
© 2021 Meta ULC. All rights reserved